Provided by Tiger Trade Technology Pte. Ltd.

Co-Diagnostics, Inc.

1.75
-0.2700-13.37%
Post-market: 1.68-0.0700-4.00%19:55 EDT
Volume:393.49K
Turnover:706.86K
Market Cap:3.67M
PE:-0.06
High:1.95
Open:1.90
Low:1.66
Close:2.02
52wk High:46.50
52wk Low:1.66
Shares:2.10M
Float Shares:1.99M
Volume Ratio:0.03
T/O Rate:19.76%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-29.0077
EPS(LYR):-37.2229
ROE:-62.12%
ROA:-37.92%
PB:0.09
PE(LYR):-0.05

Loading ...

CoSara Expands Distributor Network Across India for Co-Diagnostics Inc

Reuters
·
Jan 12

Co-Diagnostics Enacts 1-for-30 Reverse Stock Split

Reuters
·
Dec 30, 2025

Co-Diagnostics Inc - Reverse Stock Split Effective January 2, 2026

THOMSON REUTERS
·
Dec 30, 2025

Co-Diagnostics Inc - Filed Amendment to Effect Reverse Stock Split of Its Common Stock at a Ratio of 1-for-30 Shares

THOMSON REUTERS
·
Dec 30, 2025

Co-Diagnostics Inc. Granted Australian Patent for Point-of-Care PCR Testing Platform

Reuters
·
Dec 29, 2025

CoSara Diagnostics Invited to Advanced TB Diagnostics Workshop in India

Reuters
·
Dec 18, 2025

Co-Diagnostics Confirms Flu Test Effectiveness Against Emerging H3N2 Mutation

Reuters
·
Dec 17, 2025

Co-Diagnostics Unveils Portable Cloud-Connected PCR Platform at Boston Conference

Reuters
·
Dec 09, 2025

CoSara Diagnostics to Showcase New PCR Tests at VIROCON 2025

Reuters
·
Dec 09, 2025

Co-Diagnostics Inc. held shareholder meeting on reverse stock split proposal

Reuters
·
Dec 06, 2025

Co-Diagnostics Initiated at Buy by Maxim Group

Dow Jones
·
Nov 26, 2025

Co-Diagnostics Inc : Maxim Group Initiates Coverage With Buy Rating; Target Price $1.5

THOMSON REUTERS
·
Nov 26, 2025

Analysts Offer Insights on Healthcare Companies: Co-Diagnostics (CODX), Stevanato Group (STVN) and Alpha Cognition Inc (ACOG)

TIPRANKS
·
Nov 24, 2025

Co-Diagnostics Addresses Tuberculosis Test Adoption at The Union World Conference on Lung Health

Reuters
·
Nov 20, 2025

Co-Diagnostics Initiates Clinical Evaluations For Upper Respiratory Multiplex Point-Of-Care Test On Co-Dx™ Pcr Platform To Support Submission To The U.S. FDA

Reuters
·
Nov 20, 2025

Co-Diagnostics Launches Clinical Trials for Multiplex PCR Respiratory Test

Reuters
·
Nov 18, 2025

Co-Diagnostics Initiates Clinical Evaluations for Upper Respiratory Multiplex Point-of-Care Test on Co-Dx™ Pcr Platform to Support Submission to the U.S. FDA

THOMSON REUTERS
·
Nov 18, 2025

Co-Diagnostics Raises $3.8 Million in Registered Direct Offering

Reuters
·
Nov 14, 2025

Co-Diagnostics reports Q3 net loss of $5.9 million on $11.4 million in cash and securities

Reuters
·
Nov 14, 2025

Co-Diagnostics Launches Joint Venture with Arabian Eagle Manufacturing for MENA Expansion

Reuters
·
Nov 14, 2025